His primary scientific interests are in Internal medicine, Gastroenterology, Hepatitis C, Hepatitis C virus and Cirrhosis. His Internal medicine research is multidisciplinary, incorporating perspectives in Ribavirin, Sofosbuvir and Surgery. His work carried out in the field of Gastroenterology brings together such families of science as Simeprevir, Dasabuvir, Ombitasvir, Telaprevir and Model for End-Stage Liver Disease.
His Hepatitis C research includes themes of Liver biopsy, Incidence, Portal venous pressure, Viral hepatitis and Chronic liver disease. His research investigates the connection between Hepatitis C virus and topics such as Viral load that intersect with issues in Alpha interferon. His work in Cirrhosis covers topics such as Liver disease which are related to areas like Hepatitis B.
Xavier Forns mainly investigates Internal medicine, Gastroenterology, Hepatitis C, Hepatitis C virus and Liver transplantation. His Internal medicine research includes elements of Ribavirin, Sofosbuvir and Surgery. The concepts of his Gastroenterology study are interwoven with issues in Fibrosis and Liver biopsy.
His study in Hepatitis C is interdisciplinary in nature, drawing from both Decompensation, Liver function, Intensive care medicine, Hepatitis and Hepatocellular carcinoma. His Hepatitis C virus study frequently intersects with other fields, such as Viral load. The Liver transplantation study combines topics in areas such as Hepatology, Transient elastography and Pathology.
His primary areas of investigation include Internal medicine, Gastroenterology, Hepatitis C, Cirrhosis and Hepatitis C virus. His Liver disease, Liver transplantation, Hepatitis B and Portal hypertension study in the realm of Internal medicine connects with subjects such as In patient. Xavier Forns interconnects Hepatocellular carcinoma, Hepatitis B virus, Antiviral therapy and Sofosbuvir in the investigation of issues within Gastroenterology.
His Hepatitis C research is multidisciplinary, incorporating perspectives in Decompensation, Incidence, Hepatitis, Chronic liver disease and Cohort. His work investigates the relationship between Cirrhosis and topics such as Adverse effect that intersect with problems in Regimen. The various areas that Xavier Forns examines in his Hepatitis C virus study include Interferon, Asymptomatic and Deep sequencing.
Xavier Forns mostly deals with Internal medicine, Hepatitis C, Gastroenterology, Hepatitis C virus and Cirrhosis. His biological study spans a wide range of topics, including Pibrentasvir and Glecaprevir. His Hepatitis C research integrates issues from Decompensation, Liver transplantation, Chronic liver disease, Liver disease and Hepatocellular carcinoma.
His studies deal with areas such as Antiviral therapy and Hepatitis as well as Gastroenterology. The study incorporates disciplines such as Interferon, Lipid metabolism, Deep sequencing and Cell biology in addition to Hepatitis C virus. His research integrates issues of Stage, Genotype and Sofosbuvir in his study of Cirrhosis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
EASL Clinical Practice Guidelines: Management of chronic hepatitis B
C.P.G.P.P. Marcellin;G. Dusheiko;F. Zoulim;R. Esteban.
Journal of Hepatology (2009)
EASL Recommendations on Treatment of Hepatitis C
Jean-Michel Pawlotsky;Alessio Aghemo;Geoffrey Dusheiko;Xavier Forns.
Journal of Hepatology (2018)
Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model.
Xavier Forns;Sergi Ampurdanès;Josep M. Llovet;John Aponte.
Non-invasive evaluation of liver fibrosis using transient elastography ☆
Laurent Castera;Xavier Forns;Alfredo Alberti.
Journal of Hepatology (2008)
ABT-450/r-Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
Fred Poordad;Christophe Hezode;Roger Trinh;Kris V. Kowdley.
The New England Journal of Medicine (2014)
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
María Reig;Zoe Mariño;Christie Perelló;Mercedes Iñarrairaegui.
Journal of Hepatology (2016)
Renal impairment after spontaneous bacterial peritonitis in cirrhosis : incidence, clinical course, predictive factors and prognosis
Antonio Follo;Jose María Llovet;Miquel Navasa;Ramón Planas.
Hepatitis C virus kinetics during and immediately after liver transplantation.
Montserrat Garcia-Retortillo;Xavier Forns;Anna Feliu;Eduardo Moitinho.
Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation
Jose A. Carrión;Miquel Navasa;Jaume Bosch;Miquel Bruguera.
Liver Transplantation (2006)
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel.
Markus Cornberg;Homie A. Razavi;Alfredo Alberti;Enos Bernasconi.
Liver International (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: